Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
about
Topical treatments for chronic plaque psoriasisBrain-skin connection: stress, inflammation and skin agingMechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitisIncorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repairA human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl estersRestorative biological processes and healthKlf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisitionPsychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice.Longitudinal in vivo tracking of adverse effects following topical steroid treatment.Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study.Radiation-Induced Skin Injuries to Patients: What the Interventional Radiologist Needs to Know.Dermocosmetics for dry skin: a new role for botanical extracts.Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophyEffect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care.Eczema and ceramides: an update.The effect of stress on the defense systems.Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated.Epidermal barrier formation and recovery in skin disorders.Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells.Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroidsEfficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.Chronic stress suppresses the expression of cutaneous hypothalamic-pituitary-adrenocortical axis elements and melanogenesis.Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected SThe clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.In vivo expression of antimicrobial peptides in atopic dermatitis.Topical steroid therapy in atopic dermatitis in theory and practiceTopical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.Stratum corneum defensive functions: an integrated view.Interactions among stratum corneum defensive functions.Glucocorticoid therapy-induced skin atrophy.Preventive effects of multi-lamellar emulsion on low potency topical steroid induced local adverse effect.Effectiveness of conventional drug therapy of plaque psoriasis in the context of consensus guidelines: a prospective observational study in 150 patients.Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis.Skin as an endocrine organ: implications for its functionLipids and skin barrier function--a clinical perspective.Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.
P2860
Q24241239-298B93AD-8BB9-4E04-B728-33C117C5CAFBQ24563348-A28FE845-3B61-4742-A554-72C131ABD9E2Q26827984-0A081F2A-D265-4EB0-B35A-E7946D33DA9CQ27023919-5A53B7EF-55EB-41EC-8C10-D07C05AE2D22Q28118294-EAE4F689-2037-4D5D-91BF-FD6A1946BA56Q28391891-3C3762F8-4D6B-420C-B612-4F2CC28A70E0Q28593494-17D9403A-1606-4F77-9D51-9D8F703D5DC7Q30480323-76B1ADB3-1AD3-448E-B773-68DCF868D383Q30756145-BE9C4EAF-0297-4BA6-82E2-27BE2CDF8531Q33349360-BFA3DD37-3F89-46B9-A1F8-F86736692BB8Q33849647-15A91AB0-9DFB-49A5-B74E-704FA7149CEBQ34195882-9DED9E8A-52B6-43AD-BF3F-31C9BC2B4787Q34207525-629F33C5-6005-42FA-987F-489022C24604Q34300802-150BA267-3A45-4585-9F4F-C79E7412DACBQ34358580-9685CB93-C553-4949-B3BA-1C8CA0C9691AQ34481157-D7416B84-F2A0-4C4C-B9CF-B846D1D67CB5Q34488520-E4A2BCE6-A6E3-4D8F-A663-A572680122E6Q34576611-3C9B34B5-33DE-44BC-80F6-EA54519891F4Q34578650-9D22DBFD-78F3-4017-A80E-6548BE7DCA54Q34687966-24428C6B-5F4F-4F25-8044-7B5A45ED3438Q34709971-84AB8D18-0C0D-46AE-B1F0-E268A131A6E0Q35167249-634B5A75-62AE-43AD-A03A-DEDF9844BE96Q35172798-9219B0B3-605E-46D6-B4F0-8A3D0C1B84F2Q35200091-5E0A72C4-DE98-405F-91E5-E195819617DEQ35220452-5167C35E-EEB1-4424-ABA1-D1417511FA9BQ35744702-1BECC9F0-880F-4D08-908C-1443B4AAB42AQ35829085-7A7DF595-6741-4C82-8FD2-D9C8F20231CEQ35843367-86212726-36C8-4255-9789-E5940809A54CQ36228049-42DDF555-F048-4589-8D8C-A85D372E5937Q36263577-8AC3D4EC-ED02-4A47-B280-074BBD0C4AB6Q36475498-19BA5476-0A48-4800-B091-870FE3063281Q36640541-B58F1C95-17DE-43C3-A5BE-3DBA32D347F7Q36871881-EA50B9F8-9ED6-4582-A34E-01745C077981Q36991454-20728BB8-54F2-408A-88DC-33FBD6BE45E2Q37049990-AC87EF7B-3959-48FB-89E4-8CB878FF90B2Q37115130-62DCFCC4-F391-44F3-86C3-5FA51A19ED08Q37135426-D6467EC3-685B-4BEB-A909-9B5314930ED7Q37139810-B5ACA7B5-4D7F-4339-8546-192F7CF6F355Q37140319-E95AAFCF-FF30-44C6-A65D-5E4CEAA98AEEQ37164077-15424C05-760A-4687-996C-193095C4B2FA
P2860
Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Short-term glucocorticoid trea ...... for functional abnormalities.
@en
Short-term glucocorticoid trea ...... for functional abnormalities.
@nl
type
label
Short-term glucocorticoid trea ...... for functional abnormalities.
@en
Short-term glucocorticoid trea ...... for functional abnormalities.
@nl
prefLabel
Short-term glucocorticoid trea ...... for functional abnormalities.
@en
Short-term glucocorticoid trea ...... for functional abnormalities.
@nl
P2093
P1476
Short-term glucocorticoid trea ...... for functional abnormalities.
@en
P2093
Ashley J Fowler
Barbara E Brown
Debra Crumrine
Jack S Kao
Jean-Pierre Hachem
Joachim W Fluhr
Kenneth R Feingold
Mao-Qiang Man
Peter M Elias
Sung K Ahn
P304
P356
10.1046/J.1523-1747.2003.12053.X
P407
P577
2003-03-01T00:00:00Z
P5875
P6179
1009173840